PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2023 Earnings Conference Call February 28, 2024 4:30 PM ET
Company Participants
Ron Aldridge - Senior Director, IR
Matthew Klein - CEO
Eric Pauwels - CBO
Kylie O'Keefe - CCO
Pierre Gravier - CFO
Conference Call Participants
Brooke Schuster - William Blair
Rick Miller - Cantor Fitzgerald
Eric Joseph - JPMorgan
Jeff Hung - Morgan Stanley
Brian Abrahams - RBC Capital Markets
Peyton Bohnsack - TD Cowen
David Lebowitz - Citi
Gena Wang - Barclays
Paul Choi - Goldman Sachs
Joseph Schwartz - Leerink Partners
Operator
Good day and thank you for standing by. Welcome to the PTC Fourth Quarter 2023 Financial Results. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s call is being recorded.
I would now like to pass the call over to the Senior Director of Investor Relations, Ron Aldridge.
Ron Aldridge
Good afternoon and thank you for joining us today to discuss PTC Therapeutics' fourth quarter and full year 2023 corporate update and financial results.
I'm joined today by our Chief Executive Officer, Dr. Matthew Klein; our Chief Business Officer, Eric Pauwels; Chief Commercial Officer, Kylie O'Keefe; and our Chief Financial Officer, Pierre Gravier.
Today's call will include forward-looking statements based on our current expectations. Please take a moment to review the slide posted on our Investor Relations website in conjunction with the call, which contains our forward-looking statements.
Our actual results could materially differ from these forward-looking statements, as such statements are subject to risks that can materially and adversely affect our business and results of operations.
For a detailed description of applicable risks and uncertainties, we encourage you to review the company's most recent annual report on Form 10-K filed with the Securities and Exchange Commission, as well as the company's other SEC filings.
We will disclose certain non-GAAP information during this call. Information regarding our use of GAAP to non-GAAP financial measures and a reconciliation of GAAP to non-GAAP are available in today's earnings release.
With that, let me pass the call over to our CEO, Matthew Klein. Matt?
Matthew Klein
Thank you, Ron. Good afternoon and thank you for joining today's call. I'm pleased to share our fourth quarter and full year 2023 results and to provide an update on the progress of our pipeline programs as we move into what will be an exciting 2024 with a number of potential significant milestones.